Immune Tolerance Network (ITN) Symposium
The Immune Tolerance Network (ITN) is an international clinical research consortium founded by the National Institute of Allergy and Infectious Diseases (NIAID), with additional support from the Juvenile Diabetes Research Foundation (JDRF), whose mission is to accelerate the clinical development of immune tolerance therapies. The ITN develops, implements, and conducts trials of novel immune tolerance therapies in type 1 diabetes, autoimmune diseases, solid organ and islet transplantation, and allergy and asthma. ITN trials look beyond the traditional endpoints of safety and efficacy, building into each trial a complementary set of genetic, cellular, and immunological studies that explore the underlying mechanisms of tolerance and disease.
In celebration of the ITN’s 10th anniversary there will be a free one-day symposium, “Ten Years of Tolerance,” on November 1st, 2010, on the NIH campus in Bethesda, MD. The symposium will feature leading tolerance researchers from around the world and will highlight a decade of advancements in clinical tolerance and biomarker discovery. Please contact Laura Straub () if you have any questions about this event.
The full agenda can be found here: www.immunetolerance.org/symposium
For more information about the ITN, please visit www.immunetolerance.org.
If you have newsworthy information to add to the ASHI Web site, please contact kmiranda@ahint.com for consideration.